Over the counter asthma inhalers
Pro Research Analysisby 
Searched over 200M research papers
Over-the-Counter Asthma Inhalers: Safety, Effectiveness, and Risks
OTC Asthma Inhalers for Mild, Intermittent Asthma
Over-the-counter (OTC) asthma inhalers, such as epinephrine-based products like Primatene Mist, are intended for people with mild, intermittent asthma and can be safe and effective when used as directed for occasional relief of symptoms in this groupDickinson2000Aschenbrenner2019Gaynes2022. These inhalers are approved for use in individuals aged 12 and olderAschenbrenner2019Gaynes2022. However, guidelines emphasize that people with persistent or more severe asthma should be under a physician’s care and use prescription medications, such as inhaled corticosteroids, rather than relying on OTC inhalersDickinson2000Gaynes2022.
Risks of Misuse and Overuse of OTC Inhalers
Misuse or overuse of OTC asthma inhalers can lead to serious health risks, including severe adverse reactions and even deathDickinson2000Khalil2024Loh2023+1 MORE. Studies show that a significant number of people who use OTC inhalers have persistent asthma, which puts them at higher risk if they are not receiving appropriate prescription therapyDickinson2000Loh2023. Overuse of short-acting beta-agonists (SABA), which are commonly available OTC, is linked to poor asthma control, more frequent asthma attacks, increased emergency room visits, and higher risk of deathKhalil2024Price2024Loh2023. Many patients do not fully understand these risks, and lack of education about proper asthma management contributes to the problemLoh2023Hussain2025.
Patterns of OTC Inhaler Use and Asthma Outcomes
Research from various regions, including the United States, Australia, and Saudi Arabia, shows that a notable proportion of asthma patients obtain and use inhalers without a prescriptionKhalil2024Price2024Loh2023. In some studies, up to 39.6% of asthma patients reported purchasing SABA inhalers OTC, and among these, a large percentage overused them. Overuse is especially common among those with moderate to severe asthma and those who do not use preventive medications. Patients who overuse OTC inhalers experience more severe asthma exacerbations and poorer asthma control compared to those who use them appropriately or have prescriptionsKhalil2024Price2024Loh2023.
Cost-Effectiveness and Alternatives to OTC Epinephrine Inhalers
Recent analyses suggest that if as-needed budesonide-formoterol (a combination inhaled corticosteroid and long-acting beta-agonist) were made available OTC, it would be more cost-effective, improve asthma outcomes, and reduce asthma-related deaths compared to OTC epinephrine inhalers. This supports the idea that better alternatives to current OTC options could benefit underinsured or underserved populations with mild asthma.
Concerns from Healthcare Professionals and Policy Implications
Healthcare professionals and organizations have raised concerns that making asthma inhalers available OTC could undermine asthma management guidelines, lead to increased healthcare costs, and worsen asthma control at the population levelGaynes2022Milgram2014. Community pharmacists and physicians worry about patients’ reliance on quick-relief inhalers and the lack of regular follow-up and educationHussain2025Milgram2014. Improved patient education, regular monitoring, and clear labeling are recommended to help prevent misuse and ensure safe use of OTC inhalersDickinson2000Loh2023Hussain2025.
Conclusion
OTC asthma inhalers can provide quick relief for mild, intermittent asthma when used correctly, but their misuse and overuse are linked to poor asthma outcomes and increased health risksDickinson2000Khalil2024Price2024+2 MORE. Most experts and guidelines recommend that people with persistent or severe asthma should not rely on OTC inhalers and should instead seek regular medical care and use prescription medications. Better education, monitoring, and possibly safer OTC alternatives are needed to improve asthma management and patient safetyHo2023Loh2023Hussain2025+1 MORE.
Sources and full results
Most relevant research papers on this topic
Safety of over-the-counter inhalers for asthma: report of the council on scientific affairs.
Over-the-counter epinephrine inhalers are safe and effective for mild, intermittent asthma when used according to label instructions, but misuse can cause severe adverse reactions, including death.
Over-the-Counter Bronchodilators Use Among Asthmatic Patients in Al-Medina Al-Monawwara
Over-the-counter bronchodilator use among asthma patients in Al-Medina Al-Monawwara increases the risk of significant ER visits, potentially indicating less asthma control and more SABA overuse.
Cost-effectiveness of budesonide-formoterol versus inhaled epinephrine in United States adults with mild asthma.
OTC as-needed budesonide-formoterol for treating mild asthma in underinsured adults without HCP management improves asthma outcomes, prevents fatalities, and is cost-saving.
DOI